Literature DB >> 15385141

Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.

Charalampos Andreadis1, Martha Charalampidou, Nikolaos Diamantopoulos, Nikolaos Chouchos, Despina Mouratidou.   

Abstract

A 33-year-old woman with T(4c)N(3) breast cancer with metastases in the skeleton (M(1)) received five cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC regimen) before conception and during the first trimester. Salvage radiotherapy (28 Gy) was delivered during the 17th week. Tamoxifen and zolendronic acid were also administered throughout the second and third trimesters. The patient was not aware of her pregnancy until the 28th week. A female phenotypically normal infant was delivered in the 35th week of gestation by cesarean section. The child is functioning normally 12 months after delivery. The literature of anthracycline treatment during conception and the first trimester is reviewed. The effects of tamoxifen and biphosphonate therapy on the fetus during pregnancy are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385141     DOI: 10.1016/j.ygyno.2004.06.037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

Review 1.  Challenges to diagnosing colorectal cancer during pregnancy.

Authors:  Mohammad Yaghoobi; Gideon Koren; Irena Nulman
Journal:  Can Fam Physician       Date:  2009-09       Impact factor: 3.275

Review 2.  Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases.

Authors:  Barbara Buonomo; Antonella Brunello; Stefania Noli; Loredana Miglietta; Lucia Del Mastro; Matteo Lambertini; Fedro Alessandro Peccatori
Journal:  Breast Care (Basel)       Date:  2019-07-25       Impact factor: 2.860

Review 3.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

4.  Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.

Authors:  Richard J Epstein
Journal:  BMC Cancer       Date:  2007-05-30       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.